Skip to main content
. 2014 Jul 10;26(2):364–378. doi: 10.1681/ASN.2013070703

Figure 6.

Figure 6.

STC1 increases SIRT3 and UCP2 expression in vitro via AMPK. (A) STC1 activates AMPK and increases the expression of SIRT3 and UCP2 in vitro. Cultured HEK cells were treated with rSTC1 for different time points. Western blots were reacted with anti-pAMPKα1,α2, anti-AMPKα1,α2, anti-actin, anti-SIRT3, and anti-UCP2. The graph represents the mean±SEM of three independent experiments depicting densitometry values of pAMPKα1,α2, SIRT3, or UCP2 normalized to actin. P<0.05 versus time 0 minutes (0’) for #SIRT3, UCP2, and *pAMPK. (B) STC1-induced increase in SIRT3 and UCP2 expression is AMPK-dependent. On the basis of the time courses for activation of AMPK and induction of SIRT3 and UCP2 (shown in A), cultured HEK cells were treated with rSTC1 plus vehicle or rSTC1 and CC for the specified time points. Western blots were reacted with anti-pAMPKα1,α2, anti-AMPKα1,α2, anti-actin, anti-SIRT3, and anti-UCP2. AMPK activity (pAMPK) was sampled 15 minutes after treatment with rSTC1, whereas the expressions of SIRT3 and UCP2 were sampled 3 hours after treatment with rSTC1. Graphs represent the mean±SEM of three independent experiments. tAMPK, total AMPK; Veh, vehicle.